Sign In
Section Navigation
Common TitleStudy 089
Official Title Phase IV Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients
Phase Phase IV
ClinicalTrials.gov NCT00084253
Treatments
Atazanavir
Atazanavir Reyataz

Atazanavir

Tradename:ReyatazOther Names:ATVClass:Protease Inhibitors (PI)
Categories Treatment-Naive
Funding
IndustryBristol-Myers Squibb
References
  • Malan DR, Krantz E, David N, et al. 96-week efficacy and safety of atazanavir, with and without ritonavir, in a HAART regimen in treatment-naive patients. J Int Assoc Physicians AIDS Care (Chic). 2010;9:34-42.
    [PubMed Abstract]
  • Malan DR, Krantz E, David N, Wirtz V, Hammond J, McGrath D. Efficacy and safety of atazanavir, with or without ritonavir, as part of once-daily highly active antiretroviral therapy regimens in antiretroviral-naive patients. J Acquir Immune Defic Syndr. 2008;47:161-7.
    [PubMed Abstract]

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.